EarningsQ4 2022 Earnings Report

BioMarin Pharmaceutical (BMRN) Q4 2022 Earnings Report

0 Followers

MX:BMRN Q4 2022 EPS Results

Actual EPS$0.00

Consensus EPS-$1.07

Beat/MissBeat by +$1.07

One Year Ago EPS-$5.89

Actual Revenue$9.49B

Expected Revenue$9.89B

Beat/MissMissed by -$401.72M

YoY Revenue Growth+16.01%

QuarterQ4 2022

Date02/27/2023

TimeAfter Close

Conference CallMonday, February 27, 2023

MX:BMRN Upcoming Earnings

BioMarin Pharmaceutical's next earnings date is estimated for November 3, 2026, based on past reporting schedules.

MX:BMRN Q4 2022 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 03, 2026	2026 (Q3)	24.74 / -	-2.943	―
Aug 06, 2026	2026 (Q2)	17.42 / 22.07	22.621	-2.44% (-0.55)
May 04, 2026	2026 (Q1)	12.73 / 13.98	17.472	-20.00% (-3.49)
Feb 23, 2026	2025 (Q4)	3.11 / -4.41	11.77	-137.50% (-16.18)
Oct 27, 2025	2025 (Q3)	-5.15 / -2.94	10.115	-129.09% (-13.06)
Aug 04, 2025	2025 (Q2)	15.83 / 22.62	10.115	123.64% (+12.51)
May 01, 2025	2025 (Q1)	13.13 / 17.47	8.46	106.52% (+9.01)
Feb 19, 2025	2024 (Q4)	9.82 / 11.77	2.023	481.82% (+9.75)
Oct 29, 2024	2024 (Q3)	9.77 / 10.12	3.862	161.90% (+6.25)
Aug 05, 2024	2024 (Q2)	6.58 / 10.12	5.333	89.66% (+4.78)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed